Learning objectives - Clinical trial club | NCT03194542 trial: Luspatercept for the treatment of patients with anemic myelofibrosis

MPN Hub

Learning objectives

Following this symposium, participants will be able to:

Recall the mechanism of action of luspatercept
Describe the use of luspatercept in patients with anemic MF
Recall key safety and efficacy data from the NCT03194542 trial
Explain the role of luspatercept in the MF therapeutic landscape

Registration form

Registration is free. Please complete the form and submit to register.

First Name *

Last Name *

Email *

Country

Speciality

I opt in to receive information about further educational opportunities from the MPN Hub

I consent to receive emails from Scientific Education Support in relation to this session only *

I have read and agree to the terms & conditions *

The MPN Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy